Subjects: Opioid-Related Disorders -- drug therapy / Copyright: Public domain - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Opioid-Related Disorders -- drug therapy ✖ Copyright Public domain ✖

1. The opium and whisky habits, and their cure

Author(s):: Woolley, B. M. (Basil M.), 1834- author
Publication:: Atlanta, Ga. : Constitution Job Office, [1889?]
Subject(s):: Opioid-Related Disorders -- drug therapy
Alcohol-Related Disorders -- drug therapy
Nostrums

2. The opium habit: its successful treatment by the Avena sativa : a paper read before the New York State Medical Society, February 9th, 1882, with additions, giving a fuller description of its therapeutic action in different diseases, etc

Author(s):: Sell, E. H. M. (Edward Herman Miller), 1832-1920, author
Publication:: Jersey City : The Evening journal print, 1883
Subject(s):: Opioid-Related Disorders -- drug therapy
Phytotherapy
Avena

3. The opium habit and its cure, and what others say of his cures

Author(s):: Woolley, B. M. (Basil M.), 1834-
Publication:: [Atlanta?] : Atlanta Constitution Print., [1879?]
Subject(s):: Opioid-Related Disorders -- drug therapy
Nostrums

4. Opioid use disorders: HHS needs measures to assess the effectiveness of efforts to expand access to medication-assisted treatment : report to majority leader, U.S. Senate

Publication:: Washington, DC : United States Government Accountability Office, October 2017
Subject(s):: Health Services Accessibility
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Outcome Assessment (Health Care)
Community-Institutional Relations
Buprenorphine -- therapeutic use
Inservice Training
Insurance Coverage
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Prescription Drug Diversion -- prevention & control
Humans
United States
United States. Department of Health and Human Services.

5. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022
Subject(s):: Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services.

6. Medical profession endorse Manine in the treatment of morphinism or the drug "habit" disease

Publication:: St. Louis, Mo. : The Manine Medicine Company, [1913?]
Subject(s):: Opioid-Related Disorders -- drug therapy
Nonprescription Drugs

7. Dear Doctor, I wish to call your attention to our remedy, Manine, for the treatment and cure of that diseased condition of the nervous system caused by the use of morphine, laudanum, heroin or opium in any of its forms

Author(s):: Manine Medicine Company, author.
Publication:: St. Louis, Missouri : Manine Medicine Company, [1913?]
Subject(s):: Opioid-Related Disorders -- drug therapy
Nonprescription Drugs

8. Opioid use disorder: endpoints for demonstrating effectiveness of drugs for treatment

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2020
Subject(s):: Analgesics, Opioid
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

9. Opioid use disorder: barriers to Medicaid beneficiaries' access to treatment medications : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, January 2020
Subject(s):: Analgesics, Opioid -- supply & distribution
Analgesics, Opioid -- therapeutic use
Health Services Accessibility
Medicaid -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
Centers for Medicare & Medicaid Services (U.S.)

10. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020
Subject(s):: Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration